181 related articles for article (PubMed ID: 12322550)
1. Savings can be achieved if Ugandan company provides HIV drugs to employees.
AIDS Wkly; 2000 Jul; ():17-8. PubMed ID: 12322550
[TBL] [Abstract][Full Text] [Related]
2. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
Marseille E; Saba J; Muyingo S; Kahn JG
AIDS; 2006 Apr; 20(6):907-14. PubMed ID: 16549976
[TBL] [Abstract][Full Text] [Related]
3. AIDS -- why African successes are scoffed.
Ankomah B
New Afr; 1996 Sep; (344):16-7, 21. PubMed ID: 12291689
[TBL] [Abstract][Full Text] [Related]
4. Assessing business responses to HIV / AIDS in Kenya.
Roberts M; Wangombe J
AIDS STD Health Promot Exch; 1995; (2):13-5. PubMed ID: 12289839
[TBL] [Abstract][Full Text] [Related]
5. South Africa says it can't afford anti-AIDS drug AZT.
AIDS Wkly; 1999 Nov 29-Dec 6; ():20-1. PubMed ID: 12349345
[TBL] [Abstract][Full Text] [Related]
6. AIDS is your business.
Rosen S; Simon J; Vincent JR; MacLeod W; Fox M; Thea DM
Harv Bus Rev; 2003 Feb; 81(2):80-7, 125. PubMed ID: 12577655
[TBL] [Abstract][Full Text] [Related]
7. Pregnant women in AZT testing in Uganda.
Sebunya C
AIDS Anal Afr; 1998 Jun; 8(3):10. PubMed ID: 12294387
[TBL] [Abstract][Full Text] [Related]
8. The direct costs of HIV / AIDS in a South African sugar mill.
Morris CN; Cheevers EJ
AIDS Anal Afr; 2000; 10(5):7-8. PubMed ID: 12322488
[TBL] [Abstract][Full Text] [Related]
9. Analysis: AIDS and the private sector. Coping with the impact on business: positive lessons from the African experience.
Roberts M
AIDS Anal Afr; 1995 Jun; 5(3):4-5. PubMed ID: 12289040
[TBL] [Abstract][Full Text] [Related]
10. WHO / UNAIDS hail consensus on cotrimoxazole use for prevention of HIV related infections in Africa.
AIDS Wkly; 2000 Apr 17-24; ():16-7. PubMed ID: 12295853
[TBL] [Abstract][Full Text] [Related]
11. Global update: Kenya.
AIDSlink; 1993; (23):14. PubMed ID: 12159243
[TBL] [Abstract][Full Text] [Related]
12. Making drugs available.
Merriman A
AIDS Action; 1998; (41):7. PubMed ID: 12294385
[TBL] [Abstract][Full Text] [Related]
13. IXth International Conference on AIDS and STDs in Africa (ICASA), Kampala, Uganda - December 10-14, 1995.
Upham G
TB HIV; 1996; (11):21-2. PubMed ID: 12179803
[TBL] [Abstract][Full Text] [Related]
14. Why companies should intervene: a case study of the costs of HIV / AIDS to employers. Economic impact: Southern Africa.
Greener R
AIDS Anal Afr; 1998 Apr; 8(2):3-4. PubMed ID: 12293622
[TBL] [Abstract][Full Text] [Related]
15. HIV / AIDS and manufacturing in Abidjan.
Aventin L; Huard P
AIDS Anal Afr; 1997 Jun; 7(3):2-4. PubMed ID: 12347944
[TBL] [Abstract][Full Text] [Related]
16. Can AIDS drugs be afforded?
Afr Health; 1997 Nov; 20(1):7. PubMed ID: 12348380
[TBL] [Abstract][Full Text] [Related]
17. AIDS and private health costs in Zimbabwe.
Hore R
SAfAIDS News; 1997 Sep; 5(3):2-6. PubMed ID: 12222374
[TBL] [Abstract][Full Text] [Related]
18. Workplace AIDS programmes. Why employers should get involved: the example of South Africa.
Strode A; Smart R
AIDS Anal Afr; 1997 Jun; 7(3):7-8. PubMed ID: 12347946
[TBL] [Abstract][Full Text] [Related]
19. Zimbabwe: are the costs of AIDS medical care affordable?
Hore R
AIDS Anal Afr; 1993; 3(2):6-8. PubMed ID: 12318404
[TBL] [Abstract][Full Text] [Related]
20. New cure or same old story? International (Africa).
AIDS Wkly Plus; 1996 Mar; ():22-3. PubMed ID: 12319984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
